Related Experiment Video
Updated: Aug 10, 2026

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples
Published on: October 2, 2020
High frequency of aberrant p16(INK4A) expression in human breast cancer
1Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, USA.
Abstract:
The product of the CDKN2/MTS1 gene, p16(INK4A) (16), inhibits phosphorylation of the retinoblastoma protein, pRB, and thus acts as a negative cell cycle regulator. It is inactivated in a wide range of human malignancies, including breast cancer. Using an immunohistochemical approach, we studied the expression of both p16 and pRB in 104 archival breast tumors, including 63 ductal, 33 lobular, and 8 mixed carcinomas. All specimens except one were evaluable for pRB expression, but only 87 were interpretable for p16 expression, reflecting the lower abundance and greater lability of this protein. Only six tumors showed abnormal RB expression. However, 43 carcinomas (49%) were completely (35) or focally (8) negative for p16. Abnormal p16 expression did not significantly correlate with several histopathological parameters. These findings provide evidence that aberrant p16(INK4A) expression is one of the most common abnormalities in human breast cancer.
Insights
Aberrant p16(INK4A) expression is common in breast cancer. This cell cycle regulator, encoded by the CDKN2/MTS1 gene, is frequently inactivated, impacting tumor development.
Area of Science:
- Oncology
- Molecular Biology
- Cell Cycle Regulation
Background:
- The CDKN2/MTS1 gene product, p16(INK4A), is a crucial negative cell cycle regulator that inhibits retinoblastoma protein (pRB) phosphorylation.
- Inactivation of p16(INK4A) is observed in various human malignancies, including breast cancer, suggesting its role in tumorigenesis.
Purpose of the Study:
- To investigate the expression patterns of p16(INK4A) and pRB in a cohort of archival breast tumors.
- To determine the frequency and potential correlations of aberrant p16(INK4A) expression with histopathological features in breast cancer.
Main Methods:
- Immunohistochemistry was employed to assess the expression levels of p16(INK4A) and pRB proteins in 104 archival breast tumor specimens.
- Tumor specimens included ductal, lobular, and mixed carcinomas, with evaluation for both protein expression and abnormalities.
Main Results:
- While retinoblastoma protein (pRB) expression was largely normal (only 6 tumors showed abnormalities), a significant proportion of breast carcinomas exhibited abnormal p16(INK4A) expression.
- Approximately 49% of the 87 interpretable cases (43 tumors) were completely or focally negative for p16(INK4A).
- No significant correlation was found between abnormal p16(INK4A) expression and common histopathological parameters.
Conclusions:
- Aberrant p16(INK4A) expression, particularly loss of expression, is a frequent molecular abnormality in human breast cancer.
- The findings highlight the potential significance of p16(INK4A) dysregulation in the pathogenesis of breast cancer.
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

